Why the study?
Cardiac autonomic neuropathy is a major complication of diabetes mellitus linked to increased morbidity and mortality, prompting investigation into its relation with diabetes control.
Does tight diabetes control reduce the prevalence of cardiac autonomic neuropathy in diabetic patients compared to uncontrolled diabetes?
Does tight diabetes control reduce the prevalence of cardiac autonomic neuropathy in diabetic patients compared to uncontrolled diabetes?
The prevalence of cardiac autonomic neuropathy in diabetic patients is high and increases with disease duration, but does not appear to be significantly associated with the degree of glycemic control.
No takes yet. Share an insight, caveat, or question.
High asymptomatic CAN prevalence in long-duration diabetes warrants routine screening; leaves open whether tighter glycemic control prevents progression.
Vasheghani et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: